MTOR and melanoma: For instance, activation of the mTOR signaling pathway has been also explored in canine melanoma as well as in the human disease, and studies in canine melanoma cell lines have demonstrated activation of this pathway along with the inhibitory efficacy of Rapamycin and other drugs (71–73).